CCEL Stock Analysis: Buy, Sell, or Hold?
CCEL - Cryo-Cell International Inc.
$3.68
0.18 (5.14%)
▲
5d:
+2.79%
30d:
-0.81%
90d:
+9.2%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: Apr 21, 2026
0d
Get Alerted When CCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CCEL shows positive signals but monitor for confirmation. Market pricing in 1.0% growth. Moderate conviction.
💡 BUY OPPORTUNITY: CCEL shows positive signals but monitor for confirmation. Market pricing in 1.0% growth. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CCEL is currently trading at $3.68, which is considered slightly high relative to its 30-day fair value range of $3.43 to $3.73. The stock's valuation (Forward PE: 184.0) is in line with its historical norms (178.6). At these levels, the market is pricing in 1.0% annual earnings growth.
Technical Outlook: Technically, CCEL is showing sideways momentum. Immediate support is located at $3.41, while resistance sits at $3.90. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.50 (+131.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CCEL is showing sideways momentum. Immediate support is located at $3.41, while resistance sits at $3.90. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.50 (+131.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$3.43 -
$3.73
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.3%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.1%)
- BULLISH: Trading 131.0% below Wall St target ($8.50)
- BULLISH: Expecting earnings turnaround to 1.0% growth with -3.6% revenue growth
Trading Range Analysis
30-Day Trading Range
$3.43 -
$3.73
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$3.41
Resistance Level
$3.90
Current Trend
Sideways
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
184.00
Wall Street Target
$8.50
(+131.0%)
Revenue Growth (YoY)
-3.6%
Earnings Growth (YoY)
-80.5%
Profit Margin
-8.5%
Valuation Premium vs History
+1.0% premium
PE vs Historical
184.0 vs 178.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.0%
(market-implied from PE analysis)
1-Year Target
$3.72
(+1%)
2-Year Target
$3.75
(+2%)
3-Year Target
$3.79
(+3%)
3-Yr Target (if PE normalizes)
(PE: 184→179)
PE COMPRESSION
$3.68
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 184.0, Growth: -81.8%)
$2.68
(+-27%)
Base:
(SPY PE: 22.0, Growth: -81.8%)
$0.32
(-91%)
Bear:
(PE: 18.7, Growth: -81.8%)
$0.27
(-93%)
Share & Embed Analysis
Last updated: May 15, 2026 5:27 AM ET
Data refreshes hourly during market hours. Next update: 6:27 AM
Data refreshes hourly during market hours. Next update: 6:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$513 | 66 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$246 | 59 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 62 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$21 | 63 BUY |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$30 | 62 BUY |
